Respiratory Virus Vaccines Market Size, Trends, Growth & Outlook

Respiratory Virus Vaccines Market - By Type (Live-attenuated Vaccines, Inactivated, Recombinant Vaccines), By Route of Administration (Intranasal, Intramuscular, Subcutaneous), By Indication (Measles, Influenza, COVID-19, Others), By Age Group (Adults, Pediatric) By End-User (Hospitals, Physician Offices, Clinics, Pharmacies ) & Global Region - Market Size, Trends, Opportunity, Forecast 2020-2028

Industry: Life Science | Report ID: FAMI-00867 | Published on: Oct, 2020 | View: 1 | Share:         

Request Sample Enquire Before Buying Request Discount

*As the coronavirus disease (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the purchase behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.

  • Report Descripton
  • Table Of Content
  • Request Methodology
  • Request Customization

Facto Market Insights added a title on “Respiratory Virus Vaccines Market – 2020-2028” to its collection of market research reports. The study of the global respiratory virus vaccines market will include the analysis of all the comprehensive segments, along with the market size, Y-O-Y growth analysis and structure of the overall industry. The industry structure is based upon a unique combination of industry research, fieldwork, market sizing analysis, and our in-house expertise. The regional manufacturers and new market players in the respiratory virus vaccines market can also leverage the information which is available in the research report to make strategic business decisions in the industry.

The infectious coronavirus (formerly 2019-nCoV) broke out in late 2019, which has imposed a medical emergency across the globe. More than 175 countries and territories have reported cases of COVID-19. On March 11th, 2020, the WHO declared the novel coronavirus a pandemic officially. With the spread of these diseases, it is expected that the GDP of various developed & developing countries will decline in the upcoming years. Further, with the increasing instances of COVID-19 many countries went under lockdown situations to control the pandemic which is anticipated to hamper the growth of various industries. The report analyzes global impact of COVID-19 on global respiratory virus vaccines market.

The study on the market research report also includes the section of market dynamics which defines the true prospect of the market. Further, the market dynamics section is segregated into market growth factors, market trends, market opportunities and market barriers which defines the current nature and future status of the global respiratory virus vaccines market. Along with this, the market research report also covers the facts & figures related to the macroeconomic trends that are expected to impact the growth of global respiratory virus vaccines market.

Additionally, the porter’s five forces analysis demonstrates the five forces which include buyers bargaining power, suppliers bargaining power, the threat of new entrants, the threat of substitutes, and degree of competition in the global respiratory virus vaccines market. In the market research report, the porter's five forces framework explains the method for analysing the competition of the business including industry structure and the level of competition in the overall market.

Moreover, the report also covers the section of competitive landscape of the global respiratory virus vaccines market, which includes the market share and positioning of all the major players in the industry. The competitive landscape analysis provides comprehensive analysis of the company’s business and performance including company overview, financial information of market players, business strategy, revenue breakup by segment and by geography, SWOT Analysis, key product offering, marketing and distribution strategies, new product development and recent news related with the market. The recent news section is further segregated into acquisition, expansion, technology development, research & development and other market activities.

Global Respiratory Virus Vaccines Market Segmentation:

The market for office furniture is divided into five major segments which including type, route of administration, indication, age group, end user and region. The study offers a comprehensive analysis of the segmentations in the global respiratory virus vaccines market, this segmentation includes the segments which hold the major contribution into the market and also provides detailed growth parameters about the market.

By Type         

- Live-attenuated Vaccines     

- Inactivated/Killed Vaccines

- Recombinant Vaccines

By Indication                            

- Measles

- Influenza

- COVID-19

- Others

By Route of Administration

- Intranasal

- Intramuscular

- Subcutaneous

By Age Group

- Adults

- Pediatric

By End User

- Hospitals

- Physician Offices

- Clinics

- Pharmacies

By Geography

- North America (U.S. & Canada)

- Europe (Germany, United Kingdom, France, Italy, Spain, Russia and Rest of Europe)

- Asia Pacific (China, India, Japan, South Korea, Indonesia, Taiwan, Australia, New Zealand and Rest of Asia Pacific)

- Latin America (Brazil, Mexicoand Rest of Latin America)

- Middle East & Africa (GCC, North Africa, South Africa and Rest of Middle East & Africa)

Global Respiratory Virus Vaccines Market: Competitive Landscape

In the section of competitive landscape includes the market share analysis and positioning of the major & niche key players in the market. The market share analysis explains that how a firm is performing in the marketplace when it is compared to its competitors. In addition to this, the research report also includes the profiling of major & niche key players in the global respiratory virus vaccines market. Some of the key players profiled include:

  • Sanofi
  • CSL Limited
  • Merck & Co
  • AstraZeneca
  • Serum Institute of India Pvt. Ltd
  • GlaxoSmithKline plc,
  • Bharat Biotech
  • Sinovac Biotech

 

Timeline Considered for Analysis:

- 2019: Base Year

- 2020: Estimated Year

- 2020 to 2028: Forecast Period

Key Questions Answered in this Report:

  • What was the overall market size in 2019? What will be the market growth during the forecast period i.e. 2020-2028?
  • What are the most promising and high-growth trends in the overall market?
  • What are the key factors impacting market dynamics? What are the growth drivers, and restraints in the respiratory virus vaccines market?
  • What are the emerging industry trends in the global respiratory virus vaccines market?
  • What are recent development and advancement in the global respiratory virus vaccines market?
  • What merger & acquisition activities have occurred in the past 4 years and what is its impact on the market?

Get a sample pages of this report Click here

Research Methodology

Market Definition and List of Abbreviations

1. Executive Summary
2. Growth Drivers & Issues in Global Respiratory Virus Vaccines Market
3. Global Respiratory Virus Vaccines Market Trends
4. Opportunities in Global Respiratory Virus Vaccines Market
5. Recent Industry Activities, 2020
6. Porter's Five Forces Analysis
7. Market Value Chain and Supply Chain Analysis
8. Global Respiratory Virus Vaccines Market Size (USD Million), Growth Analysis and Forecast, (2020 - 2028)

9. Global Respiratory Virus Vaccines Market Segmentation Analysis, By Type
9.1. Introduction
9.2. Market Attractiveness, By Type
9.3. BPS Analysis, By Type
9.4. Live-attenuated Vaccines
9.5. Inactivated/Killed Vaccines
9.6. Recombinant Vaccines

10. Global Respiratory Virus Vaccines Market Segmentation Analysis, By Indication
10.1. Introduction
10.2. Market Attractiveness, By Indication
10.3. BPS Analysis, By Indication
10.4. Measles
10.5. Influenza
10.6. COVID-19
10.7. Others

11. Global Respiratory Virus Vaccines Market Segmentation Analysis, By Route of Administration
11.1. Introduction
11.2. Market Attractiveness, By Route of Administration
11.3. BPS Analysis, By Route of Administration
11.4. Intranasal
11.5. Intramuscular
11.6. Subcutaneous

12. Global Respiratory Virus Vaccines Market Segmentation Analysis, By Age Group
12.1. Introduction
12.2. Market Attractiveness, By Age Group
12.3. BPS Analysis, By Age Group
12.4. Adults
12.5. Pediatric

13. Global Respiratory Virus Vaccines Market Segmentation Analysis, By End User
13.1. Introduction
13.2. Market Attractiveness, By End User
13.3. BPS Analysis, By End User
13.4. Hospitals
13.5. Physician Offices
13.6. Clinics
13.7. Pharmacies

14. Geographical Analysis
14.1. Introduction
14.2. North America Respiratory Virus Vaccines Market Size (USD Million), 2020 - 2028
14.2.1. By Type
14.2.2. By Indication
14.2.3. By Route of Administration
14.2.4. By Age Group
14.2.5. By End User
14.2.6. By Country
14.2.6.1. Market Attractiveness, By End-user
14.2.6.2. BPS Analysis, By End-User
14.2.6.3. U.S. Market Size (USD Million), 2020 - 2028
14.2.6.4. Canada Market Size (USD Million), 2020 - 2028

14.3. Europe Respiratory Virus Vaccines Market Size (USD Million), 2020 - 2028
14.3.1. By Type
14.3.2. By Indication
14.3.3. By Route of Administration
14.3.4. By Age Group
14.3.5. By End User
14.3.6. By Country
14.3.6.1. Market Attractiveness, By Country
14.3.6.2. BPS Analysis, By Country
14.3.6.3. Germany Market Size (USD Million), 2020 - 2028
14.3.6.4. United Kingdom Market Size (USD Million), 2020 - 2028
14.3.6.5. France Market Size (USD Million), 2020 - 2028
14.3.6.6. Italy Market Size (USD Million), 2020 - 2028
14.3.6.7. Spain Market Size (USD Million), 2020 - 2028
14.3.6.8. Russia Market Size (USD Million), 2020 - 2028
14.3.6.9. Rest of Europe Market Size (USD Million), 2020 - 2028

14.4. Asia Pacific Respiratory Virus Vaccines Market Size (USD Million), 2020 - 2028
14.4.1. By Type
14.4.2. By Indication
14.4.3. By Route of Administration
14.4.4. By Age Group
14.4.5. By End User
14.4.6. By Country
14.4.6.1. Market Attractiveness, By Country
14.4.6.2. BPS Analysis, By Country
14.4.6.3. China Market Size (USD Million), 2020 - 2028
14.4.6.4. India Market Size (USD Million), 2020 - 2028
14.4.6.5. Japan Market Size (USD Million), 2020 - 2028
14.4.6.6. South Korea Market Size (USD Million), 2020 - 2028
14.4.6.7. Indonesia Market Size (USD Million), 2020 - 2028
14.4.6.8. Taiwan Market Size (USD Million), 2020 - 2028
14.4.6.9. Australia Market Size (USD Million), 2020 - 2028
14.4.6.10. New Zealand Market Size (USD Million), 2020 - 2028
14.4.6.11. Rest of Asia Pacific Market Size (USD Million), 2020 - 2028

14.5. Latin America Respiratory Virus Vaccines Market Size (USD Million), 2020 - 2028
14.5.1. By Type
14.5.2. By Indication
14.5.3. By Route of Administration
14.5.4. By Age Group
14.5.5. By End User
14.5.6. By Country
14.5.6.1. Market Attractiveness, By Country
14.5.6.2. BPS Analysis, By Country
14.5.6.3. Brazil Market Size (USD Million), 2020 - 2028
14.5.6.4. Mexico Market Size (USD Million), 2020 - 2028
14.5.6.5. Rest of Latin America Market Size (USD Million), 2020 - 2028

14.6. Middle East & Africa Respiratory Virus Vaccines Market Size (USD Million), 2020 - 2028
14.6.1. By Type
14.6.2. By Indication
14.6.3. By Route of Administration
14.6.4. By Age Group
14.6.5. By End User
14.6.6. By Country
14.6.6.1. Market Attractiveness, By Geography
14.6.6.2. BPS Analysis, By Geography
14.6.6.3. GCC Market Size (USD Million), 2020 - 2028
14.6.6.4. North Africa Market Size (USD Million), 2020 - 2028
14.6.6.5. South Africa Market Size (USD Million), 2020 - 2028
14.6.6.6. Rest of Middle East & Africa Market Size (USD Million), 2020 - 2028

15. Competitive Landscape
15.1. Sanofi
15.2. CSL Limited
15.3. Merck & Co
15.4. AstraZeneca
15.5. Serum Institute of India Pvt. Ltd
15.6. GlaxoSmithKline plc,
15.7. Bharat Biotech
15.8. Sinovac Biotech

Select License Type
  • Single User License $3050 USD
  • Multi-User License $4150 USD
  • Corporate User License $5250 USD

Our Clients

  • +1 518-300-1215Mon-Fri, 24Hrs
  • [email protected]We reply within an hours
  • Albany,
    NY, USA.